Keyphrases
Pharmacogenetics
100%
Age-related Macular Degeneration
100%
Ranibizumab
100%
Complement Factor H
100%
CFH Y402H
100%
Genotype
66%
Visual Acuity
33%
Risk Allele
33%
Intravitreal Ranibizumab
33%
High Risk
16%
Monotherapy
16%
Single nucleotide Polymorphism
16%
Clinical Examination
16%
Lesion Size
16%
Ophthalmological
16%
Tailored Treatment
16%
Recurrent Event Analysis
16%
Response to Treatment
16%
Fundus Photography
16%
Fluorescein Angiography
16%
Complement Factor H Gene
16%
Intravitreal
16%
Ranibizumab Injection
16%
Injection Timing
16%
Pharmacology, Toxicology and Pharmaceutical Science
Age Related Macular Degeneration
100%
Pharmacogenetics
100%
Ranibizumab
100%
Complement Factor H
100%
Cohort Study
14%
Monotherapy
14%
Retrospective Study
14%
Fluorescein
14%
Neuroscience
Age-Related Macular Degeneration
100%
Complement Factor H
100%
Ranibizumab
100%
Single-Nucleotide Polymorphism
14%
Fluorescein
14%
Angiography
14%